AGP

Artia Global Partners Portfolio holdings

AUM $389M
This Quarter Return
+18.55%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$389M
AUM Growth
+$389M
Cap. Flow
+$10.9M
Cap. Flow %
2.8%
Top 10 Hldgs %
87.23%
Holding
44
New
10
Increased
9
Reduced
7
Closed
9

Top Buys

1
INSM icon
Insmed
INSM
$43.7M
2
ARGX icon
argenx
ARGX
$36.9M
3
VRNA
Verona Pharma
VRNA
$36.5M
4
TRVI icon
Trevi Therapeutics
TRVI
$7.18M
5
REGN icon
Regeneron Pharmaceuticals
REGN
$5.6M

Top Sells

1
LLY icon
Eli Lilly
LLY
$50M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
$29M
3
PTGX icon
Protagonist Therapeutics
PTGX
$17.2M
4
ACLX icon
Arcellx
ACLX
$15M
5
MRUS icon
Merus
MRUS
$6.73M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XENE icon
26
Xenon Pharmaceuticals
XENE
$2.99B
$1.25M 0.3%
40,000
– –
BHVN icon
27
Biohaven
BHVN
$1.66B
$1.13M 0.27%
+80,000
New +$1.13M
RNA icon
28
Avidity Biosciences
RNA
$5.99B
$983K 0.24%
+34,600
New +$983K
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$2.57B
$808K 0.19%
+29,200
New +$808K
MLYS icon
30
Mineralys Therapeutics
MLYS
$1.92B
$556K 0.13%
+41,100
New +$556K
NAMS icon
31
NewAmsterdam Pharma
NAMS
$2.83B
$495K 0.12%
+27,319
New +$495K
JANX icon
32
Janux Therapeutics
JANX
$1.38B
$462K 0.11%
20,000
-18,100
-48% -$418K
TVTX icon
33
Travere Therapeutics
TVTX
$1.69B
$457K 0.11%
30,900
– –
ACLX icon
34
Arcellx
ACLX
$3.87B
– –
-229,085
Closed -$15M
CNTA
35
Centessa Pharmaceuticals
CNTA
$2.06B
– –
-35,226
Closed -$507K
ISRG icon
36
Intuitive Surgical
ISRG
$160B
– –
-3,500
Closed -$1.73M
NBIX icon
37
Neurocrine Biosciences
NBIX
$13.7B
– –
-14,700
Closed -$1.63M
NUVL icon
38
Nuvalent
NUVL
$5.61B
– –
-90,745
Closed -$6.44M
RYTM icon
39
Rhythm Pharmaceuticals
RYTM
$6.84B
– –
-50,000
Closed -$2.65M
UGL icon
40
ProShares Ultra Gold
UGL
$614M
– –
0
– –
VRDN icon
41
Viridian Therapeutics
VRDN
$1.58B
– –
-160,000
Closed -$2.16M
XBI icon
42
SPDR S&P Biotech ETF
XBI
$5.25B
– –
0
– –
ORKA
43
Oruka Therapeutics, Inc. Common Stock
ORKA
$581M
– –
-7,380
Closed -$75.7K
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-219,719
Closed -$29M
1
2